J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roth, J.
Right arrow Articles by Dobbelstein, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roth, J.
Right arrow Articles by Dobbelstein, M.
Agricola
Right arrow Articles by Roth, J.
Right arrow Articles by Dobbelstein, M.
Journal of General Virology (1999), 80, 3251-3255.
© 1999 Society for General Microbiology


Animal: DNA Viruses

Failure of viral oncoproteins to target the p53-homologue p51A

Judith Roth1 and Matthias Dobbelstein2

Gastroenterologie und Stoffwechsel, Zentrum Innere Medizin, Klinikum der Universität Marburg, Baldingerstraße, 35043 Marburg, Germany1
Institut für Virologie, Universität Marburg, Robert Koch Str. 17, 35037 Marburg, Germany2

Author for correspondence: Matthias Dobbelstein. Fax +49 6421 286 8962. e-mail dobbelst{at}mailer.uni-marburg.de

The p51/p63/KET proteins were identified based on their strong homology to the tumour suppressor p53 and a related set of proteins termed p73. All these protein species were shown to activate transcription from at least some p53-responsive promoters. To evaluate a possible role of the transcriptionally active splicing variant p51A/p63{gamma} in tumour suppression, we determined whether viral oncoproteins that inactivate p53 might also target p51A. Neither the large T-antigen of simian vacuolating virus 40 (SV40) nor the E6 protein from human papillomavirus type 18 were found to inhibit p51A-mediated transcription, whereas they strongly suppress the activity of p53. Further, SV40 T-antigen directly interacts with p53 but not detectably with p51A. Finally, a cytoplasmic mutant (K128A) of SV40 T-antigen relocalizes p53 from the nucleus to the cytoplasm, but p51A remains in the nucleus when coexpressed with cytoplasmic T-antigen. These results strongly suggest that the inhibitory effect of these viral oncoproteins is specific for p53 and does not measurably affect p51A. Thus, unlike p53, p51A does not appear to be a necessary target in virus-induced cell transformation and may not exert a role comparable to p53 in tumour suppression.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J.-W. Kim, P. I. Song, M.-H. Jeong, J.-H. An, S.-Y. Lee, S.-M. Jang, K.-H. Song, C. A. Armstrong, and K.-H. Choi
TIP60 Represses Transcriptional Activity of p73{beta} via an MDM2-bridged Ternary Complex
J. Biol. Chem., July 18, 2008; 283(29): 20077 - 20086.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. E. Ferguson-Yates, H. Li, T. K. Dong, J. L. Hsiao, and D. H. Oh
Impaired repair of cyclobutane pyrimidine dimers in human keratinocytes deficient in p53 and p63
Carcinogenesis, January 1, 2008; 29(1): 70 - 75.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. R. M. R. Amin, V. S. Thakur, R. K. Paul, G. S. Feng, C.-K. Qu, H. Mukhtar, and M. L. Agarwal
SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG
PNAS, March 27, 2007; 104(13): 5419 - 5424.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-H. Jeong, J. Bae, W.-H. Kim, S.-M. Yoo, J.-W. Kim, P. I. Song, and K.-H. Choi
p19ras Interacts with and Activates p73 by Involving the MDM2 Protein
J. Biol. Chem., March 31, 2006; 281(13): 8707 - 8715.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Welcker and B. E. Clurman
The SV40 Large T Antigen Contains a Decoy Phosphodegron That Mediates Its Interactions with Fbw7/hCdc4
J. Biol. Chem., March 4, 2005; 280(9): 7654 - 7658.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
U. M. Moll and N. Slade
p63 and p73: Roles in Development and Tumor Formation
Mol. Cancer Res., July 1, 2004; 2(7): 371 - 386.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Liu, S. Nozell, H. Xiao, and X. Chen
{Delta}Np73{beta} Is Active in Transactivation and Growth Suppression
Mol. Cell. Biol., January 15, 2004; 24(2): 487 - 501.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
C. S. Sullivan and J. M. Pipas
T Antigens of Simian Virus 40: Molecular Chaperones for Viral Replication and Tumorigenesis
Microbiol. Mol. Biol. Rev., June 1, 2002; 66(2): 179 - 202.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. J. Di Como, M. J. Urist, I. Babayan, M. Drobnjak, C. V. Hedvat, J. Teruya-Feldstein, K. Pohar, A. Hoos, and C. Cordon-Cardo
p63 Expression Profiles in Human Normal and Tumor Tissues
Clin. Cancer Res., February 1, 2002; 8(2): 494 - 501.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
M. S. Irwin and W. G. Kaelin
p53 Family Update: p73 and p63 Develop Their Own Identities
Cell Growth Differ., July 1, 2001; 12(7): 337 - 349.
[Full Text] [PDF]


Home page
Cancer Res.Home page
B.-J. Park, S.-J. Lee, J. I. Kim, S.-J. Lee, C.-H. Lee, S.-G. Chang, J.-H. Park, and S.-G. Chi
Frequent Alteration of p63 Expression in Human Primary Bladder Carcinomas
Cancer Res., July 1, 2000; 60(13): 3370 - 3374.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1999 by the Society for General Microbiology.